TABLE 1.
EAD (N = 22) | IF (N = 21) | p-value | |
---|---|---|---|
Characteristics (mean ± SD) | |||
Pathway control: OXPHOS capacity per mg wet mass | |||
FAO pathway F P [pmol·s−1·mg−1] | 10.75 ± 4.37 | 10.26 ± 4.23 | ns |
NADH pathway N P [pmol·s−1·mg−1] | 4.12 ± 2.88 | 4.43 ± 3.09 | ns |
Succinate pathway S P [pmol·s−1·mg−1] | 42.94 ± 12.62 | 40.04 ± 13.19 | ns |
Convergent pathway FNS P [pmol·s−1·mg−1] | 43.50 ± 13.25 | 40.61 ± 14.06 | ns |
FAO pathway FCR (relative to FNS) | 0.25 ± 0.06 | 0.24 ± 0.06 | ns |
NADH pathway FCR (relative to FNS) | 0.09 ± 0.06 | 0.11 ± 0.06 | ns |
Succinate pathway FCR (relative to FNS) | 0.99 ± 0.03 | 0.99 ± 0.03 | ns |
Coupling control: Succinate pathway characteristics | |||
LEAK respiration S L [pmol·s−1·mg−1] | 12.07 ± 5.64 | 9.67 ± 3.67 | ns |
OXPHOS capacity S P [pmol·s−1·mg−1] | 40.76 ± 16.26 | 38.83 ± 11.19 | 0.94 |
Cytochrome c control efficiency, 1-S P /S Pc | 0.17 ± 0.12 | 0.11 ± 0.09 | 0.12 |
P-L control efficiency, 1-S L /S P | 0.70 ± 0.08 | 0.76 ± 0.06 | 0.02 |
Statistically significant differences are bold.